Category: Flu Virus

Page 103«..1020..102103104105..110120..»

Free flu vaccinations offered Nov. 1 | News | clevelandbanner.com – Cleveland Daily Banner

October 29, 2023

The Tennessee Department of Health is encouraging all Tennesseans not to wait to get their annual flu vaccinations as the best prevention against getting or spreading the flu virus.

The elderly, people with chronic medical conditions, pregnant women, and young children are all at risk of severe complications if they get the flu, Bradley County Health Department Director Brittany Hopkins said. Flu activity is expected to grow from this point forward, in Tennessee and nationally. So, dont delay getting a flu vaccine.

All Tennesseans, 6 months and older, are eligible to get the flu vaccine. Nationally, 7.5 million illnesses, 105,000 hospitalizations, and 6,300 deaths could be prevented annually if more people choose to get a flu vaccine. The flu vaccine is safe and effective and can protect against the most common types of circulating flu viruses, and the flus worst symptoms.

Bradley County Health Department will provide free flu vaccines to the public, from 4-7 p.m. on Wednesday, Nov. 1, at the Cleveland Family YMCA (220 Urbane Road NE, Cleveland) at its annual Fight Flu 23 event.

The local health department will join more than 100 Tennessee Department of Health locations across Tennessee where the flu vaccine will be free, beginning Nov. 1.

No appointment is needed to get the vaccine. Visit TDHs Fight Flu webpage, to find other locations where the vaccine is available and to get more information.

Fight Flu 23 is TDHs annual, large-scale preparedness exercise where medical staff and teams at county health departments statewide practice their emergency response plans using free flu vaccine for the public.

Avoid close contact with those who are sick with the flu. If you become sick, limit contact with others as much as possible and stay at home. Wash your hands often with soap and water, and cover your nose and mouth with a tissue, or with your arm at the elbow, when you cough or sneeze.

If you do get the flu, your doctor may prescribe antiviral drugs as treatment. Antivirals can make flu symptoms milder and shorten the time someone is sick with the flu. Antivirals are not available as an over-the-counter flu treatment and should be taken only as prescribed by a physician or health care provider.

Flu symptoms can range from mild to severe and include muscle aches, fever, fatigue, sore throat, cough, headaches, and stuffy or runny noses.

The mission of the Tennessee Department of Health is to protect, promote and improve the health and prosperity of people in Tennessee. Learn more about TDH services and programs at http://www.tn.gov/health.

See the article here:

Free flu vaccinations offered Nov. 1 | News | clevelandbanner.com - Cleveland Daily Banner

Dr. Francisco R. Velzquez: Fall is here, and with it the beginning of … – The Spokesman Review

October 29, 2023

Francisco R. Velzquez, M.D., S.M., FCAP

By Francisco R. Velzquez, M.D., S.M., FCAP

The autumnal equinox came and went, and now fall colors adorn the Pacific Northwest landscape. The busy summer season is over, students are back in school, and believe it or not there are already signs of the upcoming seasonal holidays and festivities. These holiday previews seem to start earlier every passing year.

In addition to signaling changing weather patterns, fall also means that an increase in respiratory viral infections is coming. The seasonality and cyclical nature of respiratory viral diseases has been recognized for thousands of years. One of the earliest documented accounts of the seasonality of some viruses can be found in the Book of Epidemics written by Hippocrates around 400 BC. The causal relationship of temperature, humidity and human activities have been examined and debated for years.

With colder temperatures and more inclement weather, indoor activities increase, as well as the time that we all spend around each other in close proximity. Although warm, cozy and festive, these activities contribute to the transmission of viruses with familiar names like influenza, and respiratory syncytial virus. Others like adenovirus and rhinovirus, which cause the common cold, can be seen throughout the year. SARS-CoV-2, which causes COVID-19, has not demonstrated an identifiable seasonal pattern, but the same cold-weather behaviors can cause an increase in COVID-19 transmission too.

As we saw last year, we anticipate seeing flu, RSV and COVID-19 infections coincide. Lets review what we know, and how to best protect our community.

Lets start with the flu, whose expectant seasonality helps us to predict what transmission will look like. The flu season in the Southern Hemisphere is usually between April and September, giving us an early look at which flu types are circulating, the severity of illness, and the season longevity. What happens in the other half of the world does not mean we will see the exact same pattern, but it does inform the strategy for the upcoming flu season, including the composition of the current flu shot and the potential for severe disease. Flu season in the Northern Hemisphere can start as early as October and extend into April and May. Based on preliminary data from five countries in the Southern Hemisphere, the flu vaccines may have prevented up to 50% of potential hospitalizations. The quadrivalent vaccine for our flu season is available and being actively administered.

RSV season usually starts in September and runs through January. We have already seen an increase in positive tests and cases in the southeast portion of the country. Historically, such regional increases are typical with increased activity moving north and west over the following two or three months. This year we have two therapeutic options which were not available before. Two vaccines have been released this year for people 60 and older. Recommendations will be made individually using shared clinical decision making, which means age, comorbidities, and other variables will be taken into consideration. One of the vaccines has also been approved for pregnant women between 32 and 36 weeks of pregnancy during September through January. This provides up to six months of protection once the baby is born.

In addition, a monoclonal antibody compound can be given to babies under 8 months of age who are entering their first RSV season. Children who are 8 to 19 months old, who are at increased risk for severe disease, and who are entering their second RSV season can also receive this treatment.

Lastly, COVID-19 continues to be present in the environment. Members of the Omicron family, which have been with us for a long time, continue to mutate and become more effective at transmission. Cases around the country have increased over the past few weeks, including here in Spokane County. This fall, a reformulated vaccine was made available, which takes into consideration the newer sublineages. This type of reformulation isnt new. It happens every year with the flu vaccine as we determine which strains have the highest probability to cause disease.

Given the person-to-person transmission that each of these viruses is known for, it is important to follow a few very simple precautions:

Know your personal risk for severe disease and the risk for those around you, including family, friends, and co-workers.

Know the transmission risk in your community so you can plan your activities accordingly check transmission rates at covid.srhd.org and the Respiratory Illness Dashboard at doh.wa.gov.

Wash your hands thoroughly and often.

Properly cover your sneezes and coughs.

If you feel sick, get tested, stay home, and monitor your symptoms.

Dont forget to test and mask as recommended.

And, very importantly, talk to you provider about what vaccines are important for you, and when to get them.

Generally, I recommend you start thinking about getting your vaccinations after Labor Day and be completed with the process before Halloween. That makes it easy to remember. The best way to prevent these respiratory viruses is by getting the vaccines each year.

Stay safe, stay well and lets do our best to have great fall and winter seasons.

Francisco R. Velzquez, M.D., S.M., FCAP, is health officer for the Spokane Regional Health District.

Originally posted here:

Dr. Francisco R. Velzquez: Fall is here, and with it the beginning of ... - The Spokesman Review

Alberta’s COVID-19 and flu vaccine uptake could be better, expert says – CBC.ca

October 29, 2023

Calgary

Share on Facebook Share on Twitter Share by Email

Posted: October 27, 2023

Two weeks into the roll out of Alberta's fall immunization campaign, there are concerns uptake may not be keeping pace with the spread of COVID-19 and influenza.

The province's respiratory virus dashboard began reporting immunization statistics for this season on Thursday evening.

It shows 358,741 Albertans (7.9 per cent) had the rolled up their sleeves for the flu shot as of Oct. 21. By the end of last year's flu season, immunization coveragetopped out at 28 per cent.

COVID-19 vaccine uptake is lower, with a total of 236,649(5.2 per cent) having received those shots.

"What we've seen is a pretty steep uptake since these clinics opened," said Craig Jenne, professor in the department of microbiology, immunology and infectious diseases at the University of Calgary.

"[But] they're still nowhere near the level we need for a degree of community protection."

In both cases, the vast majority of doses were distributed last week (Oct. 16 - 21), when the general public first had access to the shots. Care homes had an earlier roll out.

The Calgary and Edmonton zones had the highest vaccination rates for both illnesses and pharmacies gave out the lion's share of doses.

Jenne is particularly concerned about the uptake of the COVID-19 vaccine.

"We know COVID isin the community. We know those cases have been escalating quite rapidly at hospitals. ... So it's probably more pressing to get that number up to at least the level we are seeing with the flushots."

He points to provincial datashowing 113 Albertans have died due to COVID-19 since the end of August, including seven people under the age of 60. Seven of the 57 ICU admissions have been people under the age of 20.

"This is not simply that the older people in Alberta need to get vaccinated. This is a vaccine that's protective across multiple age groups," Jenne said. "We really need to see those numbers start ticking up if we want to avoid significant illness over the holidays."

Jenne warned the number of COVID deaths reported since the end of August alone rivals the number of influenza deaths the province sees in some entire flu seasons.

Alberta's latest COVID vaccine roll out has been bumpy. The provincial government increased a limit on the number of doses pharmacies could order per week, after concerns were raised about cancelled appointments.

But some pharmacists continued to report supply issues during the second week of the immunization campaign.

Alberta's COVID positivity rate remains high at 17.8 per cent. A total of 1,214 people have been hospitalized since the end of August.

When it comes to influenza, 51 people have been hospitalized so far this season and one person hasdied.

Jennifer Lee is a CBC News reporter based in Calgary. She worked at CBC Toronto, Saskatoon and Regina before landing in Calgary in 2002. If you have a health or human interest story to share, let her know. Jennifer.Lee@cbc.ca

See more here:

Alberta's COVID-19 and flu vaccine uptake could be better, expert says - CBC.ca

Wastewater sequencing reveals community and variant dynamics of … – Nature.com

October 29, 2023

Probe-based capture drives viral enrichment

We developed a comprehensive viral capture approach using a diverse probe set across ten different sites on a weekly basis for nearly 1year. The probes (TWIST Comprehensive Viral Capture Panel) are directed against a panel of 3153 different human and animal virus genomes. As part of an initiative from the Texas Epidemic Public Health Institute23, composite 24-h wastewater influent was collected from six treatment plants in Houston, Texas, USA and four plants El Paso, Texas, USA from May 2022 through February 2023 (Fig.1A). Wastewater treatment plant catchment areas varied between 10,000 and 400,000 people (estimated 618,148 people served in Houston and 751,982 in El Paso County). These sites were chosen because they allowed us to examine the breadth and robustness of our approach across two large cities with different characteristics. Houston and El Paso also differ in size and diversity, have contrasting climate and rainfall (El Paso dry and Houston humid), are geographically distant (almost 1200 kilometers), and have different patterns of human travel (El Paso a border city with thousands of daily cross-border commuters, Houston a coastal city with one of the largest ports in the world).

A Map of wastewater catchment areas in Houston and El Paso, TX. The colored areas refer to the sites in each city (EP=4, Houston=6). B The treelike object was drawn with hierarchical taxonomical labels (kingdom, phylum, class, order, family, genus, species) rather than multiple sequence alignments due to independent origins of different virus phyla. Tip point size corresponds to number of wastewater samples with the virus detected, and color corresponds to the skew of the species to Houston (red) or El Paso (blue). C Number of distinct virus strains detected per sample from each wastewater treatment plant. D Rarefaction curves measuring distinct virus strains detected as more samples were analyzed. Lines represent average strains detected while shaded bands represent minimum and maximum values from 50 permutations. E Genome coverage of detected virus genome/segments for each sample. F Percentage of reads aligned to virus pathogen genome database in paired control (no-probe) and treatment (capture with the TWIST Comprehensive Virus Research Panel) groups. n=18 biologically independent samples. Boxplots are defined as: center line=median, lower and upper box-bounds=25th and 75th data percentiles, and whiskers extend to the minimum and maximum values.

The efficacy of probe-based enrichment methods was tested on 18 pilot samples. Following clearance of solids and nucleic acid extraction using methods designed for SARS-CoV-2 detection24, we first sequenced and examined viral read numbers from unenriched samples. Low proportions of viral reads were derived from these unenriched samples (4 78 aligned reads out of 9.8 18.0 million total reads), with 0 to 1 total mammalian viruses detected. In contrast, utilizing the TWIST Comprehensive Viral Research Panel probes on the same extractions, a 3,374-fold enrichment in the proportion of virus reads was observed (Fig.1F) (14.9 thousand 407.0 thousand aligned reads out of 11.6 24.2 million total reads), with 42 to 128 total mammalian viruses detected).

Read mapping-based virus detection and abundance measurement was conducted using EsViritu, a bioinformatics tool we developed for this purpose (Fig.S1). EsViritu leverages sequence information to sensitively detect mammalian viruses and filter out false positives (see materials and methods) (https://github.com/cmmr/EsViritu).

Applying these methods to 363 longitudinal wastewater samples, we detected 28 viral families, 77 genera, 191 species, and 465 distinct virus strains in total (Fig.1B), with a median of 54 to 98 strains detected per sample, depending on the wastewater treatment plant (Fig.1C). Furthermore, rarefaction analysis of virus strains showed that the unique detections were not saturated, and additional virus strains are likely to be detected in future samples (Fig.1D). A median of 28.5 reference genomes or segments had sequencing reads aligning to over 90% of their length with an additional 41 (median) genomes or segments with over 50% alignment (Fig.1E). From a methodological standpoint, this emphasizes the potential for in-depth analysis of circulating viruses beyond abundance measurements.

To infer the quantitative dynamic range for pathogen detection of this assay, we added in lab-grown respiratory syncytial virus A (RSV) virions to real wastewater samples (samples were previously determined to have no detectable RSV). Based on a stepwise dilution series, we could accurately detect and quantify RSV from a spike-in of 51 genome copies to 4 million genome copies with a Pearson correlation of at least R=0.975 (Fig.S2).

Having established a capture-based approach that offers the prospect of a comprehensive virome analysis of complex wastewater samples, we next asked whether signals generated from sequencing data mirror trends observed from publicly available clinical datasets. Case data from select viral pathogens, namely SARS-CoV-2, influenza virus, and monkeypox virus, were obtained for Houston and, when available El Paso, from local or state government sources. We started first with SARS-CoV-2, as wastewater levels have previously been correlated with case data25. Using the reads per kilobase of transcript per million filtered reads (RPKMF) as a proxy for relative virus levels in a given sample, there was a positive correlation between case data and positivity rate for SARS-CoV-2 summer and winter waves and the wastewater signal in Houston (Fig.2A, S3A, B, R=0.50.78) and case data from El Paso (Fig.2B, R=0.59 - 0.73). This finding is strengthened by the fact that a second orthogonal technique to measure SARS-CoV-2 levels in wastewater (i.e., qPCR which is the current standard) was also closely correlated with the RPKMF (Fig.S3C, D) for both Houston (R=0.64) and El Paso (R=0.84).

A SARS-CoV-2 wastewater sequencing abundance compared to reported cases (top) and scatter plot with Pearson correlation coefficients and p-value for two-sided test between wastewater sequencing abundance compared to reported cases of SARS-CoV-2 (bottom) in Houston, TX. B SARS-CoV-2 wastewater sequencing abundance compared to reported cases (top) and scatter plot with Pearson correlation coefficients and p-value for two-sided test between wastewater sequencing abundance compared to reported cases of SARS-CoV-2 (bottom) in El Paso, TX. C Influenza wastewater sequencing abundance compared to reported Weekly Percentage of Visits with Discharge Diagnosed Influenza (top) and scatter plot with Pearson correlation coefficients and p-value for two-sided test between wastewater sequencing abundance compared to Weekly Percentage of Visits with Discharge Diagnosed of Influenza (bottom) in Houston, TX. D Monkeypox virus wastewater sequencing abundance compared to reported Mpox cases (top) and scatter plot with Pearson correlation coefficients and p-value for two-sided test between wastewater sequencing abundance. E Heatmap for all ten wastewater sites for presence/absence and abundance for 11 pathogens of major concern (y-axis) across the entire study period (x-axis).

Similarly, Influenza A Virus abundance in the virome sequencing data was highly concordant with reporting of Weekly Percentage of Visits with Discharge Diagnosed Influenza in the Houston area (Fig.2C, R=0.9). Influenza variants H3N2 and H1N1 were also resolved in our data, concordant with clinical subtyping of this flu season in Texas (see Data and Materials Availability). Once more, the virome sequencing data was highly correlated with qPCR measurements from the same samples (Fig.S3E, F, R=0.57 0.73). Finally, a Monkeypox (Mpox) outbreak occurred in the summer of 2022 in several U.S. cities. Rather strikingly, monkeypox virus was detected numerous times at low abundance in Houston wastewater samples (Fig.2D, R=0.46) in our virome dataset, even though only 1,050 cases were reported in the entire Houston area between July and November 2022. Meanwhile, no detection events of monkeypox virus were recorded from El Paso wastewater samples, consistent with only 10 total reported clinical cases in this metro area.

Encouraging from a detection and possibly public health standpoint, 11 categories of major viral pathogens were routinely detected and could be tracked over the sampling period (Fig.2E), including noroviruses, rotavirus A, hepatitis A virus, RSV, parainfluenza viruses, and enterovirus D68. Interestingly, at times, there were different trends in virus levels observed in both cities and at different periods of the year (Fig.S4).

We wished to understand how the human wastewater virome changed over space and time. Important variables in the structure of virome communities were realized by generating t-distributed stochastic neighbor embedding (t-SNE) plots from the virus abundance data of each sample. There was a stark separation of the samples by the city of collection and date of collection (Fig.3AB). Virus species from several families showed an uneven distribution between Houston and El Paso (Fig.S5A). For example, while we expect most viruses to have a prevalence bias towards El Paso due to higher median levels of strain detection per site (Fig.1C), El Paso had especially strong signals from many Parvoviridae and Sedoreoviridae whereas Houston samples had higher prevalence of many Calicivirdae and Astroviridae, the reasons for which are currently unknown (Fig.S5A).

A t-SNE of wastewater samples using virome abundance data, showing different cities/sites. B t-SNE of wastewater samples using virome abundance data, showing samples over time. C Temporal analysis of intra-site community changes. Each dot is a comparison between two samples. The x-axis measures days in between sampling. The y-axis measures Bray-Curtis dissimilarity between the samples. D Bray-Curtis dissimilarity between samples taken +/- 7days apart, comparing samples from the same site, different site but same city, and different city. ****Represents t-test p-value<1e-04. Different City vs Same Site, p=6.2e164. Different City vs Same City, p=2.1e214. Same City vs Same Site, p=2.9e30.

To assess community dynamics over time, all samples from each site were compared to each other using the Bray-Curtis dissimilarity statistic (Fig.3C). In general, as time went on, the composition of the virome in samples diverged such that samples taken closer in time were quite similar, whereas those separated by many months were very different. Interestingly, a possible exception to the temporal divergence rule can be seen in samples taken from the wastewater treatment plant serving Houstons large intercontinental airport, which likely reflects a transient population of world travelers (Fig.3C, HOU R5). Here, the compositional dissimilarity was poorly correlated with the passing of time, possibly due to flux of the virome from incoming people. On the other hand, as the data collection approaches 1year and the seasons repeat, samples from 3 of 4 El Paso sites seem to be re-converging on their community structures from the previous year. In general, dissimilarity follows a pattern where sites from different cities are more different than sites within the same city, and samples from the same site are more similar than everything else (Fig.3D, Fig.S5B). Finally, we assessed the impact of human population size on virome diversity. The alpha diversity (Shannons statistic) was measured for each sample (Fig.S5C), and the average diversity and population of the service area for each site were plotted (Fig.S5D). Average diversity increases from catchment populations of 10,000 to 100,000 inhabitants, but the diversity values level off with greater numbers of people. Collectively, this data confirms that the structure of wastewater virome communities are substantially determined by temporal and geospatial factors.

A handful of viruses had high or complete genome coverage across many wastewater samples and were therefore suitable for variant analysis. Although a single lineage seemed to dominate the sample read abundance for some virus strains, many samples had a mix of two or more lineages. Therefore, allelic variants were measured by the frequency of non-synonymous mutations compared to the reference genome. We focused on three examples.

Astrovirus MLB1, which has a seroprevalence in Americans close to 100%26, was the virus contained at high genome coverage in the most samples in our dataset. The variant landscape of Astrovirus MLB1 was largely dictated by the city-of-origin of the sample (Fig.4E), with gene-specific mutations in the capsid, ORF1a, and ORF1b showing strong regional localization in time (Fig.4B, Fig.S6B). Human Adenovirus 41 is an enteric virus associated with diarrhea and, possibly, hepatitis27 in children and was also quite common in wastewater. This virus splits into two major lineages (Fig.4A, D, Fig.S6A), with the hypervariable capsid (hexon) gene having a lot of diversity28. Although both lineages dominated in samples from either city, each city had one lineage that was more common. JC Polyomavirus, which is secreted in the urine, commonly establishes long, asymptomatic infections in a high proportion of the population29. Consistent with non-acute, rarely transmitted infections, the variant landscape of this virus seems to lack meaningful spatiotemporal structure and most samples appear to have a diversity of lineages (Fig.4C, F, Fig.S6C).

A Genome map of Human Adenovirus 41 (middle) with non-synonymous variants displayed above (Houston, TX) and below (El Paso, TX) according to genome position (X-axis) and date (Y-axis). B Like (A) but with Astrovirus MLB1. C Like (A) but with JC Polyomavirus. D t-SNE of non-synonymous variant frequency of astrovirus MLB1. E Like (D) but with JC Polyomavirus. F Like (D) but with JC Polyomavirus.

See original here:

Wastewater sequencing reveals community and variant dynamics of ... - Nature.com

HIV could become like receiving a flu jab and require only one injection a year to keep it under control – Daily Mail

October 29, 2023

Treatment for HIV could become like receiving a flu jab and require only one injection a year to keep the condition under control, according to a leading pharmaceutical boss.

Deborah Waterhouse, chief executive of ViiV Healthcare, which specialises in the treatment of HIV/AIDS, told The Mail on Sunday that the company wants to release an annual jab within the next decade.

ViiV owned by British pharma giant GlaxoSmithKline (GSK) currently offers an injection that people with HIV need to take every two months to keep their virus levels suppressed.

Sold under the brand name Cabenuva, it has been available on theNHS since April last year as an alternative to the more common daily tablets.

But ViiV is working to develop a new version that will extend the gap between injections to four months and Ms Waterhouse said there was also 'a path towards' an injection that needs to be administered only twice a year.

She added that once-a-year treatments to suppress the virus were also becoming close at hand and could potentially be available in the early 2030s.

'You can get to a point where you only have to treat somebody once a year, almost like taking a flu vaccine,' she said

Meanwhile, ViiV is planning to offer the four-monthly injection by 2027 and the six-monthly dose by the end of the decade.

If left untreated, Human immunodeficiency virus (HIV) can lead to acquired immune deficiency syndrome (AIDS), which reduces the body's ability to defend itself against illness and infection.

The condition has been responsible for tens of millions of deaths since it was first identified in the early 1980s.

However, advances in medical treatment since then mean that these days someone with HIV can have a normal life expectancy provided they continue to take the medication.

Most current treatments still require patients to take the daily tablets, but ViiV says that reducing the number of doses will not just keep virus levels low, but also reduce the anxiety around the condition.

HIV is estimated to affect around 100,000 people in the UK.

Read the original:

HIV could become like receiving a flu jab and require only one injection a year to keep it under control - Daily Mail

FDA says getting Covid shot on same day as certain flu vaccines may raise risk of strokes in elderly people – – Daily Mail

October 29, 2023

By Connor Boyd Health And Science Editor For Dailymail.Com and Cassidy Morrison Senior Health Reporter For Dailymail.Com 12:47 26 Oct 2023, updated 17:24 26 Oct 2023

The Covid vaccine may be linked to a small increase in stroke risk when given alongside a high-dose flu shot, health officials say.

A new analysis by the Food and Drug Administration found the link was clearest in adults over 85 and only applied to thePfizer and Modernabivalent Covid booster vaccines.

The FDAsaid the risk might stem from the flu vaccine alone and be completely unrelated to the Covid shots. Regardless, the report said the risk is still very small.

There were roughly three strokes or stroke-like events called transient ischemic attacks for every 100,000 doses given.

For comparison, in 2022 the death rate from Covid in over-85s was 1,224 per 100,000, with US health experts saying vaccination still outweighs the small risk.

It is the second analysis by health officials to flag a possible association with strokes and seniors after getting the combination of seasonal vaccines.

Meanwhile, a separate analysis by the FDA flagged up a small increase in the incidence of seizures after Covid vaccinations in children ages two to five.

The papers were posted online last week, and have not yet been vetted for publication in a scientific journal. Experts in vaccine safety said the studies were well done.

Both studies were observational, meaning they cannot show a causal link, just an association.

Still,many scientists have credited the body's inflammatory response to vaccines with creating a domino effect of physiological changes leading to stroke and possibly seizures.

In the first analysis, FDA officials analyzed medical claims of nearly 5.4 million Americans aged 65 and older who were enrolled in the government-run health insurance program Medicare.

Researchers looked at the high-dose Fluzone seasonal flu shot, designated specifically for seniors because it contains quadruple the amount of flu protection compared to a normal shot.

They wanted to examine the effect of receiving the Fluzone shot and the Moderna or Pfizer bivalent Covid booster on the same day, looking specifically at rates ofnon-hemorrhagic stroke (NHS) and transient ischemic attack (TIA), also referred to as a 'mini stroke'.

Researchers at the Kaiser Family Foundation in California, found 52 percent of adults said they 'definitely' or 'probably' weren't getting the updated Covid booster this year.

Both types of stroke are caused by a blood clot that blocks blood flow to the brain.

Scientists do not know for sure what exactly causes a vaccine to increase the risk of stroke, and still say it is a rare occurrence.

Studies have shown that soon after receiving a Covid jab, people's blood pressure increased, meaning the heart was working harder than it normally would.

Over time, stress causes damage to the inner lining of blood vessels and narrowing of arteries, creating the perfect condition for a dangerous clot.

But the rise in blood pressure following vaccination is typically temporary, whereas the degree of stress on the arteries leading to a stroke accumulates more gradually.

There is also a risk that the vaccine will cause a strong, abnormal immune response that turns on itself and causes severe inflammation, affecting normal blood flow to the brain.

The group that received a high-dose flu shot and the Moderna bivalent booster had an increased risk of a transient or 'mini' stroke of 35 percent.

The group that got a flu shot and the bivalent Pfizer booster had a 20 percent increased risk.

Further analysis into the link between stroke and flu vaccines alone among more than 6.9 million seniors found that shot increased their risk of stroke by about nine percent, a small yet significant rise.

Because researchers could not find a statistically significant link between stroke and Covid boosters alone, this finding suggested to researchers that it was perhaps the flu vaccine alone that was driving stroke risk.

Still, the risk of suffering a stroke after receiving both a high-dose flu shotas well as a Pfizer or Moderna bivalent booster was low for both.

In absolute terms, there were an additional 3.1 strokes per 100,000 doses following the Pfizer and flu shots and 3.3 strokes per 100,000 doses of the flu and Moderna shots.

The risk of suffering a stroke following a Covid infection is far higher than that after getting a booster shot.

A 2022 study in the journal Nature Medicinereported that military veterans who survived the first 30 days of Covid infection had a 52 percent increased risk of suffering a stroke as well as a 49 percent increased risk of a 'mini stroke'.

A straightforward way to mitigate risk would be to space out vaccines by a couple of weeks, and getting the jabs in different arms rather than receiving both in the upper arm.

The researchers did not dispute the fact that the benefits of getting vaccinated far outweigh the risk of getting severely ill and possibly dying. As President Joe Biden said last fall: 'I really believe this is why God gave us two arms one for the flu shot and the other one for the COVID shot.'

In the second analysisconducted by the FDA, researchers found a very tenuous link between seizures in children ages two to five and older iterations of the Pfizer and Moderna vaccines.

They looked at health data of more than 4.1 million American children ranging in age from six months to 17 years old who had received the vaccines through April 2023. At that point, these types of monovalent vaccines were removed from the FDA's list of approved shots and replaced by the updated bivalent varieties.

There were eight seizures in children six months to five years old reported to the Centers for Disease Control and Prevention's voluntary vaccine side effect reporting database.

Children ages two to five had a slightly higher seizure risk after receiving a Covid vaccination compared to the background seizure rates in the general population in 2020, when overall rates of infectious disease were lower thanks to social distancing.

A signal that the shots prompted seizures disappeared, however, when the researchers compared it to 2022 rates when infections among children came roaring back.

According to the study's authors, the association between convulsions and shots should be taken with a grain of salt.

They said: 'Since febrile seizures can be common in young children for a variety of reasons; the analysis may have identified febrile seizures unrelated to the vaccination later in the risk window.'

Most of those seizures were linked to fevers, not unexpected because many vaccines induce fevers in children, an indication that they have jumpstarted the immune system.

Seizures triggered by fever are relatively common among infants and young children. A rapid temperature increase in the body interferes with normal electrical patterns in the brain, which experts believe leads to seizures.

And infections from flu, Covid, and respiratory syncitial virus are known to cause fever in children, and all of these staged a powerful comeback in 2022.

The benefits of vaccinating outweighed the known and potential risks of Covid infection, they said. Yet millions of parents have declined to get their children vaccinated because the youngest Americans typically fare far better than older adults and seniors.

Continued here:

FDA says getting Covid shot on same day as certain flu vaccines may raise risk of strokes in elderly people - - Daily Mail

What will this winter’s flu season look like? – Gavi, the Vaccine Alliance

October 27, 2023

Flu season is about to hit the northern hemisphere. Last year's was particularly severe, as reduced exposure to influenza viruses during the COVID-19 pandemic combined with the resurgence of other respiratory infections such as respiratory syncytial virus (RSV) place dhuge pressure on hospital beds in many countries.

The northern hemisphere's flu season typically begins in October and can run until the end of May. While it is impossible to be certain of how the coming months will pan out, there are reasons to be optimistic that this year's flu season will not be quite as bad particularly if people take up the offer of seasonal flu vaccines.

The northern hemisphere's flu season follows the southern hemisphere's season.

While influenza viruses change and impact populations differently, the southern hemisphere's recent experiences can provide some indication of which influenza strains are likely to be circulating, how well vaccines might perform and the intensity of the upcoming northern flu season.

During 2023, the number of flu cases reported across all southern hemisphere zones has been comparable to the same reporting period in 2022. In fact, based on data from South Africa and Australia, "the season looks [to be] the most typical one since pre-pandemic," said Dr Tom Peacock, an influenza researcher at Imperial College London, UK.

In Australia, the total number of cases has also been broadly comparable to 2022 although influenza deaths and admissions to intensive care have been relatively low.

Interestingly, only 11% of those admitted to hospital with confirmed influenza were adults aged 65 or older, whereas children aged under 16 years accounted for 73% of admissions. One possible explanation might be relatively low uptake of influenza vaccine among children compared to previous years.

Another could be the relatively higher circulation of influenza B one of three types of influenza virus that can cause disease in humans (the others being influenza A and C).

"As flu B comes round less often, children, who are newer to the yearly flu epidemics than adults, are more likely to be susceptible," said Punam Mangtani, Professor of Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM), UK. "This may be a reason for the greater proportion of children among those hospitalised."

The best way to prevent severe flu infections is vaccination, but the influenza vaccine works better in some years than in others. For instance, the 2010-11 vaccine was 60% effective at preventing flu hospitalisations, while the 2014-15 vaccine was only 19% effective. This is because the flu virus keeps changing, and while the flu vaccine is modified each year, the decision about which viruses to target is made months in advance (in February for this year's northern hemisphere vaccine).

Across the southern hemisphere, the main circulating viruses this season have been the influenza A/(H1N1)pdm09 and H3N2 viruses, and the Victoria lineage influenza B virus. The good news is that these are genetically similar to those targeted by the 2023-24 northern hemisphere influenza vaccine formulation, a recent analysis by the US Centers for Disease Control and Prevention (CDC) analysis suggests. They were also well-matched to those targeted by the 2023 southern hemisphere vaccine.

Based on flu hospitalisations in Latin America and the Caribbean recorded between March and July, the CDC estimates that the southern hemisphere's vaccine reduced the risk of hospitalisation by 52%. "This vaccine might offer similar protection if these viruses predominate during the coming Northern Hemisphere influenza season," the report said.

"In particular, [these interim] estimates indicate a significant reduction in hospitalization associated with the predominant influenza A/(H1N1)pdm09 virus among young children and older adults.

"Vaccination is one of the most effective ways to prevent influenza and severe associated outcomes. Health authorities worldwide should encourage influenza vaccination for persons at increased risk for severe disease, including young children, persons with preexisting health conditions, and older adults, as well as those at increased risk for exposure to or transmission of influenza virus, such as health care personnel."

During the Autumn and Winter of 2022-23, many countries in the Northern Hemisphere were hit by a "tripledemic" of influenza, RSV and COVID-19, placing severe strain on public health systems. Reported rates of RSV in many southern hemisphere countries have been low in recent months. In Australia, they have been relatively high, although some of this could be due to increased surveillance for the disease.

WHO has warned that COVID-19 remains an uncertain threat, as new variants keep emerging. "It is also likely that COVID-19, influenza and RSV will be co-circulating this autumn and winter," said Dr Marc-Alain Widdowson, who leads WHO's High-threat Pathogen team. "This scenario is of concern as it would increase the risk to vulnerable populations and put further pressure on health services."

Besides getting vaccinated, he stressed that simple precautions such as wearing a mask in crowded, enclosed or poorly ventilated spaces, hand washing, improved ventilation indoors, covering coughs and sneezes with a tissue or bent elbow, and staying home if you are unwell, could all help to reduce transmission of these viruses.

See the original post here:

What will this winter's flu season look like? - Gavi, the Vaccine Alliance

Experts Answer FAQ About Flu & Flu Shots | Johns Hopkins … – Johns Hopkins Bloomberg School of Public Health

October 27, 2023

Every fall and winter, Google searches rise with questions about the flu and flu vaccines. We collected some of the most popular flu-related searches and got trustworthy answers from two Bloomberg School experts.

Joshua Sharfstein, MD, is a professor of Health Policy and Management and vice dean for Public Health Practice and Community Engagement. Caitlin Rivers, PhD, MPH, senior scholar at the Johns Hopkins Center for Health Security and assistant professor in Environmental Health and Engineering.

Flu is a virus.

CR: Flu can spread through the air, which means being near someone who has influenza can put you at risk.

JS: It also means wearing a mask can be helpful.

Learn more: How Flu Spreads

CR: Yes, influenza is real. In the U.S., flu causes hundreds of thousands of hospitalizations each year and tens of thousands of deaths. It is real, it can be dangerous, and it is definitely worth protecting yourself against.

Learn more: Preventative Steps Against Flu

CR: It can be dangerous. This is particularly true for older adults, infants, and people who are pregnant. Particular groups are at greater risk for severe flu illness. Even for people who are young and healthy, who are unlikely to experience severe illness, flu is a really tough illness.

Learn more: People at Higher Risk for Flu Complications

CR: A little bit, yes. The seasonal influenza virus that we get vaccinated against every year is an influenza virus, as was the Spanish flu of 1918, but they are not exactly the same." Influenza is a virus that likes to change. Every year it's a little bit different, which is part of the reason you have to get vaccinated every year.

JS: It is free for a lot of people. There are requirements that vaccines be covered for many people with insurance so they don't have to do co-pays. And public health departments have the flu vaccine. So it's a good idea to check either with your insurer or with your health department to be able to get it for free.

Find a flu vaccine appointment or clinic near you

JS: Yes, the flu vaccine is a shot. Some people can receive the vaccine in nasal spray form; that's the live virus version. But the other version, the most common version, is an intramuscular shot.

JS: Yes, it is. The flu vaccine that's recommended during pregnancy is the inactivated one (injection), not the live virus vaccine (nasal spray).

CR: I have had two pregnancies and I was vaccinated for both of them. So thats a personal attestation that it is safe and effective.

Learn more: Flu Vaccine Safety and Pregnancy

JS: Today, at the end of October 2023, yes, vaccines are available all over the country and it is possible to find in your community.

Find a flu vaccine appointment or clinic near you

CR: It can. The flu vaccine can reduce your chance of developing severe illness by about half, which is pretty impressive considering that the influenza virus can be pretty tricky to match up against. But we do a pretty good job. And so it can prevent pneumonia.

CR: Most flu vaccines are made in eggs, which is why there are sometimes questions about whether people who have egg allergies are able to receive the flu vaccine. There are other ways to make flu vaccines. The egg-based approach is not the only manufacturing approach, but I believe it's most common.

Learn more: How Influenza (Flu) Vaccines Are Made

JS: Yes.* If people with egg allergies have concerns, it's always good to talk to their doctor about getting vaccinated. But in general, it is a very safe vaccine. If people have had an allergic reaction to a flu vaccine, that's where you really have to be especially cautious.

Read more: Flu Vaccine and People with Egg Allergies

CR: Flu vaccines work by giving your body a little peek at the proteins, or the composition of the virus, and stimulate your body to make defenses against that recipe, if you will. That way, when you encounter the influenza virus in the wild, your body is already revved up and familiar and is able to really combat that virus.

JS: If you're not vaccinated, just like for COVID or something else, your body has to take the full weight of that initial infection while it's starting to respond. If you're vaccinated, you can respond right away. It's sort of like you have the bouncers already ready for the virus.

JS: No, you cannot get the flu from a flu shot. And that is because flu shots don't actually contain live flu virus.

CR: Sometimes when you get a vaccine, whether flu or really any vaccine, you can feel crummy for a couple of hours, maybe a day. And that's your immune system doing its job and ramping up. But it is different than having an active infection. So if you have some aches or a little fever after a vaccine, that's normal and it will pass.

JS: There is a misconception of if I can get sick after a vaccine, then what's the point of getting a vaccine? But vaccines prevent the severe complications. People are getting that flu shot in order to not get a severe case of pneumonia or go into the hospital or even die. And that's not going to happen from a flu shot.

JS: Yes, it is possible. And in part that's because the vaccine isn't perfectly matched up with the virus. The viruses are constantly changing, and vaccines don't fully prevent infection against flu. But the good news is you're less likely to be hospitalized or get really sick. So you're not really getting a flu vaccine to be perfectly healthy and never worry about the fluyou're getting a vaccine to be able to keep doing the things you enjoy.

JS: The typical flu season is at the end of the year and the beginning of the next year. November, December, January, February; it can vary a bit. Some health departments also track how prevalent flu is in their area based on doctor and emergency room visits and positive flu tests. If you hunt around on your health department's website, you may find a curve that shows you where your community is in terms of flu season.

Follow CDC guidance and updates for this years flu season

CR: Seasonal influenza circulates most often in winter. December and January are usually the peak months, but it's possible to get flu in summer, particularly flu B, which is one of the types of influenza that is more common in summer. But generally, activity is much lower in the summer.

JS: For most people, the best time is just at the beginning of flu season or a little bit before. October would be my preferred month.

CR: I heard flu before boo recently, as in, you should get your flu shot before Halloween.

JS: They usually become available in the late summer or early fall.

Find a flu vaccine appointment or clinic near you

*A serious reaction is unlikely to occur, but if you have had a severe reaction in the past or are concerned about an egg allergy, please check with a health care provider. There are flu shot formulations made without eggs that may be recommended to you. For more information, visit the CDC's article, Flu Vaccine and People with Egg Allergies.

See the rest here:

Experts Answer FAQ About Flu & Flu Shots | Johns Hopkins ... - Johns Hopkins Bloomberg School of Public Health

Bird flu spreads to more Minnesota turkey flocks in October – Star Tribune

October 27, 2023

Five Minnesota counties have now reported bird flu outbreaks at turkey farms this month as bird flu continues to threaten a key state industry.

Since the resurgence of the virus in Meeker County early in October, cases have been confirmed in Blue Earth, Becker, Kandiyohi and Redwood counties. More than 100,000 birds were killed to prevent further spread, according to the Minnesota Board of Animal Health.

About 180,000 birds were culled at two sites in Meeker County earlier this month as the virus struck a large commercial operation in Minnesota for the first time this year.

Bird flu is typically spread by migrating birds in spring and fall. Minnesota, which raises more turkeys than any other state, is in a major migratory bird corridor and lost 4 million birds to bird flu a last year.

The 2022 outbreak was the deadliest wave of bird flu in U.S. history and has claimed nearly 60 million birds since it began.

Health officials have maintained the virus, officially called highly pathogenic avian influenza or H5N1, is not a threat to the food supply. It is extremely unlikely for a human to contract the virus, which is spread by direct contact with avian body fluids and feces.

A different strain of bird flu spreading in Cambodia recently infected and killed an adult and child who had direct contact with infected poultry, according to the Centers for Disease Control and Prevention.

"There is no indication that these two human infections with H5N1 pose a threat to the U.S. public," the CDC said Oct. 12.

Wild birds and other animals can carry bird flu, and Minnesota has reported more bird flu in wild birds than any other state, according to the U.S. Department of Agriculture. More than a dozen ducks and a peregrine falcon have been found with the virus in Minnesota this month.

Avoid touching sick or dead animals found in the wild. Report dead birds in the wild and any irregularities in backyard poultry flocks and commercial operations to the state Avian Influenza Hotline at 1-833-454-0156.

The autumn bird flu outbreak has so far been minor compared to the last year's spread, which sent turkey and egg prices soaring. As of Tuesday, and with less than a month until Thanksgiving, the market for frozen and fresh turkeys is "steady" according to the USDA.

Prices for frozen whole turkeys remain below average and are ranging $1 to $1.20 per pound nationwide after reaching nearly $2 per pound during last year's avian flu-stricken holiday season.

Fresh hens recently climbed to $1.40 per pound, matching the three-year average for late October.

"Turkey and poultry supplies have recovered over the last year," Farm Bureau economist Bernt Nelson wrote earlier this month. "This means there is plenty of turkey and the lower prices that come with strong supplies to go around for Thanksgiving."

Original post:

Bird flu spreads to more Minnesota turkey flocks in October - Star Tribune

Pfizer’s combination Covid, flu vaccine will move to final-stage trial after positive data – CNBC

October 27, 2023

CFOTO | Future Publishing | Getty Images

Pfizer on Thursday said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results in an early to mid-stage study.

That moves the pharmaceutical giant and its German partner BioNTech one step closer to winning a potential regulatory approval for a combination shot for Covid and the flu. Earlier this year, Pfizer said it hopes to launch a vaccine targeting those two respiratory viruses in 2024 or later.

Pfizer and other vaccine makers like Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against respiratory viruses that typically surge around the same time of the year.

"This vaccine has the potential to lessen the impact of two respiratory diseases with a single injection and may simplify immunization practices," Annaliesa Anderson, Pfizer's head of vaccine research and development, said in a release.

Pfizer CEO Albert Bourla said during an investor call earlier this month that he believes the convenience offered by combination vaccines will "unlock a significant potential by improving the vaccination rates."

Covid vaccine rates in the U.S. were bleak last year, and could look the same this year.

The trial measured the safety, tolerability and efficacy of Pfizer's combination vaccine candidates among adults ages 18 to 64. The trial also compared the combination vaccines to a licensed influenza vaccine and Pfizer's bivalent Covid shot, which targets the omicron variants BA.4 and BA.5 and the original strain of the virus.

The results showed that "lead" formulations of Pfizer's combination vaccine demonstrated robust immune responses to influenza A, influenza B and Covid strains, according to Pfizer.The safety profiles of the combination vaccine candidates were also consistent with the company's Covid vaccine.

Pfizer and BioNTech are also developing a vaccine that targets both Covid and RSV. Meanwhile, both Moderna and Novavax are developing their own combination shots.

Here is the original post:

Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive data - CNBC

Page 103«..1020..102103104105..110120..»